These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 35842683)

  • 1. Prostaglandin E1 reduces apoptosis and improves the homing of mesenchymal stem cells in pulmonary arterial hypertension by regulating hypoxia-inducible factor 1 alpha.
    Jiang DT; Tuo L; Bai X; Bing WD; Qu QX; Zhao X; Song GM; Bi YW; Sun WY
    Stem Cell Res Ther; 2022 Jul; 13(1):316. PubMed ID: 35842683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
    Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects of hypoxia-preconditioned bone marrow-derived mesenchymal stromal cells and their extracellular vesicles in experimental pulmonary arterial hypertension.
    Braga CL; Santos RT; da Silva CM; de Novaes Rocha N; Felix NS; Medeiros M; Melo MM; Silva JD; Teixeira DE; Neves CC; Rocco PRM; Cruz FF; Silva PL
    Life Sci; 2023 Sep; 329():121988. PubMed ID: 37517581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension.
    de Mendonça L; Felix NS; Blanco NG; Da Silva JS; Ferreira TP; Abreu SC; Cruz FF; Rocha N; Silva PM; Martins V; Capelozzi VL; Zapata-Sudo G; Rocco PRM; Silva PL
    Stem Cell Res Ther; 2017 Oct; 8(1):220. PubMed ID: 28974252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in mice.
    Aliotta JM; Pereira M; Wen S; Dooner MS; Del Tatto M; Papa E; Goldberg LR; Baird GL; Ventetuolo CE; Quesenberry PJ; Klinger JR
    Cardiovasc Res; 2016 Jun; 110(3):319-30. PubMed ID: 26980205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LincRNA-p21 promotes mesenchymal stem cell migration capacity and survival through hypoxic preconditioning.
    Meng SS; Xu XP; Chang W; Lu ZH; Huang LL; Xu JY; Liu L; Qiu HB; Yang Y; Guo FM
    Stem Cell Res Ther; 2018 Oct; 9(1):280. PubMed ID: 30359325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-mediated mesenchymal stem cells homing to the lung reduces monocrotaline-induced rat pulmonary hypertension.
    Jiang L; Song XH; Liu P; Zeng CL; Huang ZS; Zhu LJ; Jiang YZ; Ouyang HW; Hu H
    Cell Transplant; 2012; 21(7):1463-75. PubMed ID: 22525351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
    Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q
    Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of prostaglandin E1 (PGE1) on pulmonary hypertension and lung vascular remodeling in a rat monocrotaline model of human pulmonary hypertension].
    Ono S; Tanita T; Hoshikawa Y; Song C; Maeda S; Tabata T; Noda M; Ueda S; Ashino Y; Fujimura S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Aug; 33(8):862-7. PubMed ID: 7474567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced pluripotent stem cell-derived exosomes attenuate vascular remodelling in pulmonary arterial hypertension by targeting HIF-1α and Runx2.
    Chi PL; Cheng CC; Wang MT; Liao JB; Kuo SH; Lin KC; Shen MC; Huang WC
    Cardiovasc Res; 2024 Mar; 120(2):203-214. PubMed ID: 38252891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synergistic therapeutic effect of hepatocyte growth factor and granulocyte colony-stimulating factor on pulmonary hypertension in rats.
    Guo Y; Su L; Li Y; Guo N; Xie L; Zhang D; Zhang X; Li H; Zhang G; Wang Y; Liu C
    Heart Vessels; 2014 Jul; 29(4):520-31. PubMed ID: 23933910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension.
    Kanki-Horimoto S; Horimoto H; Mieno S; Kishida K; Watanabe F; Furuya E; Katsumata T
    Circulation; 2006 Jul; 114(1 Suppl):I181-5. PubMed ID: 16820570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Umbilical Cord Blood Derived Mesenchymal Stem Cells in Monocrotaline-induced Pulmonary Artery Hypertension Rats.
    Lee H; Lee JC; Kwon JH; Kim KC; Cho MS; Yang YS; Oh W; Choi SJ; Seo ES; Lee SJ; Wang TJ; Hong YM
    J Korean Med Sci; 2015 May; 30(5):576-85. PubMed ID: 25931788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction.
    Huang B; Qian J; Ma J; Huang Z; Shen Y; Chen X; Sun A; Ge J; Chen H
    Stem Cell Res Ther; 2014 Feb; 5(1):22. PubMed ID: 24507665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis.
    Lan YW; Choo KB; Chen CM; Hung TH; Chen YB; Hsieh CH; Kuo HP; Chong KY
    Stem Cell Res Ther; 2015 May; 6(1):97. PubMed ID: 25986930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stromal cell-derived exosomes improve pulmonary hypertension through inhibition of pulmonary vascular remodeling.
    Zhang S; Liu X; Ge LL; Li K; Sun Y; Wang F; Han Y; Sun C; Wang J; Jiang W; Xin Q; Xu C; Chen Y; Chen O; Zhang Z; Luan Y
    Respir Res; 2020 Mar; 21(1):71. PubMed ID: 32192495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantation of mesenchymal stem cells improves right ventricular impairments caused by experimental pulmonary hypertension.
    Luan Y; Zhang ZH; Wei DE; Zhao JJ; Kong F; Cheng GH; Wang YB
    Am J Med Sci; 2012 May; 343(5):402-6. PubMed ID: 21876426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal Dose and Timing of Umbilical Stem Cells Treatment in Pulmonary Arterial Hypertensive Rats.
    Lee H; Kim KC; Choi SJ; Hong YM
    Yonsei Med J; 2017 May; 58(3):570-580. PubMed ID: 28332363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of mesenchymal stem cell delivery via a novel cardiac bioscaffold on right ventricles of pulmonary arterial hypertensive rats.
    Schmuck EG; Hacker TA; Schreier DA; Chesler NC; Wang Z
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1005-H1013. PubMed ID: 30822119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.